Blood Storage Related Mortality and Adverse Effects in Trauma Patients
Is Long-Term Blood Storage Related With Increased Mortality and Adverse Effects in Severely Injured Trauma Patients?
1 other identifier
observational
300
1 country
1
Brief Summary
The purpose of this retrospective study is to examine the following factors related to blood storage time in severely injured trauma patients who received large blood transfusions:
- 1.The effect of blood storage time on the patient's 28-day mortality rate.
- 2.The relationship between storage time and other health problems that the patient may develop (such as heart disease, vascular occlusion, respiratory failure, infection, and organ failure).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 17, 2025
CompletedFirst Posted
Study publicly available on registry
January 14, 2026
CompletedStudy Start
First participant enrolled
January 17, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
February 17, 2026
February 1, 2026
5 months
December 17, 2025
February 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
28-day Mortality
The aim of this study was to evaluate the effect of red blood cell and whole blood storage duration on 28-day mortality in severely injured trauma patients (injury severity score \>15) undergoing massive transfusion.
At the day of 28 after massive blood transfusion
Secondary Outcomes (5)
28-day Morbidity - Cardiac Ischemia
At the day of 28 after massive blood transfusion
28-day morbidity- thromboembolic events
At the day of 28 after massive blood transfusion
28-day morbidity- nosocomial infection
At the day of 28 after massive blood transfusion
28-day morbidity- multiple organ failure
At the day of 28 after massive blood transfusion
28-day morbidity- acute respiratory failure
At the day of 28 after massive blood transfusion
Study Arms (1)
Group 1
The study will include patients aged 18-75, with an ISS \>15, who presented directly from the injury scene and received massive transfusion (defined as \>10 packed RBC (PRBC) units in the first 24 hours or ≥3 units in 1 hour) between January 1, 2023, and October 1, 2025. Data will be extracted from hospital information systems and anesthesia records. The storage duration for each transfused unit (from collection to transfusion) will be recorded.
Eligibility Criteria
In our study, patients between the ages of 18-75, directly from the scene of injury, ISS\>15 and who received massive blood transfusion (\>10 packed RBC units in the first 24 hours, with an alternative definition of greater than or equal to 3 packed RBC units transfused in 1 hour) will be included in the study at University of Florida Jacksonville Shands Hospital between the dates 1 January 2023 to 1 31 December 2025.
You may qualify if:
- Patients between 18-75 years of age,
- Injury Severity Score\>15 and have received massive blood transfusions in our hospital from 1 January 2015 to 31 December 2025
- The patients admitted because of trauma and undergoing surgery
You may not qualify if:
- Patients with known cardiac or vascular diseases such as heart failure or malignant hypertension, those under anticoagulant treatment
- Patients with known serious kidney (on dialysis), lung, liver diseases, those under anticoagulant treatment
- Super obese patients with body mass index (BMI) 50 or above
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UF Health Jacksonville (Shands Hospital)
Jacksonville, Florida, 32209, United States
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
ayten saracoglu
University of Florida
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 17, 2025
First Posted
January 14, 2026
Study Start
January 17, 2026
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
February 17, 2026
Record last verified: 2026-02